Literature DB >> 6130780

Loss of acetoacetate coenzyme A transferase activity in tumours of peripheral tissues.

M J Tisdale, R A Brennan.   

Abstract

The presence of succinyl-coenzyme A: acetoacetate CoA--transferase (3-oxo acid-CoA transferase), an initiator of ketone body utilization in non-hepatic tissue was examined in a number of animal and human tumours of peripheral tissues. While enzyme levels in heart, kidney, lymphocytes and bladder were high, the tumours contained low or non-detectable levels of transferase activity, comparable with that of normal liver. The activities of acetoacetyl-CoA thiolase paralleled that of the transferase, except for the high activity in liver, and in all cases the tumour content of the enzyme was lower than that of the brain. The activity of 3-hydroxybutyrate dehydrogenase was similar in both normal and tumour tissue. The results indicate that tumours of non-hepatic tissues may be unable to metabolize ketone-bodies and suggest a therapeutic strategy for selective starvation of the tumour by dietary modification.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6130780      PMCID: PMC2011283          DOI: 10.1038/bjc.1983.38

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

1.  Plasma unesterfiled fatty acid concentrations in neoplastic disease.

Authors:  P S MUELLER; D M WATKIN
Journal:  J Lab Clin Med       Date:  1961-01

2.  Rapid loss of ATP by tumor cells deprived of glucose: contrast to normal cells.

Authors:  G E Demetrakopoulos; B Linn; H Amos
Journal:  Biochem Biophys Res Commun       Date:  1978-06-14       Impact factor: 3.575

3.  Some aspects of nitrogen and energy metabolism in cancerous subjects: a review.

Authors:  G B MIDER
Journal:  Cancer Res       Date:  1951-11       Impact factor: 12.701

4.  Effect of ketone infusions on amino acid and nitrogen metabolism in man.

Authors:  R S Sherwin; R G Hendler; P Felig
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

5.  3-Oxo acid coenzyme A transferase activity in brain and tumors of the nervous system.

Authors:  M Fredericks; R B Ramsey
Journal:  J Neurochem       Date:  1978-12       Impact factor: 5.372

6.  Beta-hydroxybutyrate dehydrogenase activity in liver and liver tumors.

Authors:  K Ohe; H P Morris; S Weinhouse
Journal:  Cancer Res       Date:  1967-08       Impact factor: 12.701

7.  The oxoacyl-coenzyme A thiolases of animal tissues.

Authors:  B Middleton
Journal:  Biochem J       Date:  1973-04       Impact factor: 3.857

8.  Oxidation of branched chain amino acids by isolated hearts and diaphragms of the rat. The effect of fatty acids, glucose, and pyruvate respiration.

Authors:  M G Buse; J F Biggers; K H Friderici; J F Buse
Journal:  J Biol Chem       Date:  1972-12-25       Impact factor: 5.157

9.  Purification and characterization of a lipolytic factor (toxohormone-L) from cell-free fluid of ascites sarcoma 180.

Authors:  H Masuno; N Yamasaki; H Okuda
Journal:  Cancer Res       Date:  1981-01       Impact factor: 12.701

10.  Potentiation by clofibrate of in-vivo tumor inhibition by hydrazine sulfate and cytotoxic agents, in Walker 256 carcinosarcoma.

Authors:  J Gold
Journal:  Cancer Biochem Biophys       Date:  1978
View more
  38 in total

1.  Perspective: Do Fasting, Caloric Restriction, and Diets Increase Sensitivity to Radiotherapy? A Literature Review.

Authors:  Philippe Icard; Luc Ollivier; Patricia Forgez; Joelle Otz; Marco Alifano; Ludovic Fournel; Mauro Loi; Juliette Thariat
Journal:  Adv Nutr       Date:  2020-09-01       Impact factor: 8.701

Review 2.  The ketogenic diet for the treatment of malignant glioma.

Authors:  Eric C Woolf; Adrienne C Scheck
Journal:  J Lipid Res       Date:  2014-02-06       Impact factor: 5.922

Review 3.  The Role of Glucose Modulation and Dietary Supplementation in Patients With Central Nervous System Tumors.

Authors:  Roy E Strowd; Stuart A Grossman
Journal:  Curr Treat Options Oncol       Date:  2015-08

4.  The pathway of ketogenesis in rumen epithelium of the sheep.

Authors:  B Leighton; A R Nicholas; C I Pogson
Journal:  Biochem J       Date:  1983-12-15       Impact factor: 3.857

5.  Cancer as a metabolic disease.

Authors:  Thomas N Seyfried; Laura M Shelton
Journal:  Nutr Metab (Lond)       Date:  2010-01-27       Impact factor: 4.169

6.  A ketogenic diet increases transport and oxidation of ketone bodies in RG2 and 9L gliomas without affecting tumor growth.

Authors:  Henk M De Feyter; Kevin L Behar; Jyotsna U Rao; Kirby Madden-Hennessey; Kevan L Ip; Fahmeed Hyder; Lester R Drewes; Jean-François Geschwind; Robin A de Graaf; Douglas L Rothman
Journal:  Neuro Oncol       Date:  2016-05-03       Impact factor: 12.300

7.  Glycemic modulation in neuro-oncology: experience and future directions using a modified Atkins diet for high-grade brain tumors.

Authors:  Roy E Strowd; Mackenzie C Cervenka; Bobbie J Henry; Eric H Kossoff; Adam L Hartman; Jaishri O Blakeley
Journal:  Neurooncol Pract       Date:  2015-05-26

8.  Ketone-body metabolism in tumour-bearing rats.

Authors:  A M Rofe; R Bais; R A Conyers
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

Review 9.  A framework for examining how diet impacts tumour metabolism.

Authors:  Evan C Lien; Matthew G Vander Heiden
Journal:  Nat Rev Cancer       Date:  2019-09-17       Impact factor: 60.716

Review 10.  Metabolic Strategies for Inhibiting Cancer Development.

Authors:  Philippe Icard; Mauro Loi; Zherui Wu; Antonin Ginguay; Hubert Lincet; Edouard Robin; Antoine Coquerel; Diana Berzan; Ludovic Fournel; Marco Alifano
Journal:  Adv Nutr       Date:  2021-07-30       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.